Our Pricing

Understanding Wegovy Doses: Complete UK Dosing Guide

Published on: June 03, 2026

Wegovy doses follow a carefully structured escalation protocol designed to minimise side effects while maximising weight loss outcomes. As a UK-registered pharmacy team, we've guided thousands of patients through the Wegovy dosing schedule, and understanding each dose step is essential for treatment success. This comprehensive guide explains every Wegovy dose, from the 0.25mg starting dose through to the 2.4mg maintenance dose, with transparent UK pricing and clinical evidence.

What Are the Available Wegovy Doses in the UK?

Wegovy doses are available in five distinct strengths, each delivered via a pre-filled single-dose injection pen. The available wegovy doses are 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg, with each strength colour-coded for easy identification[1]. This graduated dosing system allows patients to build tolerance gradually whilst their body adapts to semaglutide, the active pharmaceutical ingredient.

Each Wegovy dose pen contains a fixed amount of semaglutide solution designed for once-weekly subcutaneous administration. The structured wegovy doses escalation protocol typically spans 16-20 weeks before reaching the therapeutic maintenance dose of 2.4mg weekly[1]. At Cured Pharmacy, we supply all wegovy doses from £69.00, with transparent pricing displayed before your online consultation with our UK-registered prescribers.

The dose progression is not arbitrary—clinical trials demonstrated that this specific wegovy doses schedule significantly reduces gastrointestinal side effects compared to rapid escalation. In the STEP clinical trial programme, participants following the graduated dosing protocol reported better treatment adherence and tolerability than those in earlier studies using faster titration schedules[2].

Wegovy Doses Escalation Schedule: Step-by-Step Protocol

The complete wegovy doses escalation follows this evidence-based schedule: 0.25mg for 4 weeks, 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, then 2.4mg as the maintenance dose[1]. Each four-week period allows pharmacological steady-state to be achieved before progressing to the next strength.

Following the structured wegovy doses protocol is crucial for treatment success. In STEP 1 trials, participants who adhered to the full escalation schedule achieved an average weight loss of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group[2]. Rushing through wegovy doses or skipping steps increases the risk of intolerable side effects and treatment discontinuation.

Some patients may require extended time at intermediate wegovy doses if they experience persistent side effects. Our prescribers can modify the escalation timeline whilst maintaining the overall dosing framework, ensuring each patient progresses at a pace that balances efficacy with tolerability. This individualised approach to wegovy doses management is part of our comprehensive care model.

Starting Wegovy Doses: The First Four Weeks

The initial wegovy doses begin at 0.25mg once weekly for four weeks. This starting dose is sub-therapeutic—it's not designed to produce significant weight loss but rather to allow your gastrointestinal system to adapt to semaglutide's effects on gastric emptying and appetite signalling[1]. During this phase, patients typically experience minimal side effects, though mild nausea may occur in approximately 20-25% of users.

After completing four weeks at the 0.25mg starting dose, patients progress to 0.5mg weekly for another four weeks. This second wegovy doses tier begins to produce measurable appetite suppression and modest weight reduction. Our clinical team at Cured Pharmacy monitors patient progress throughout this escalation, ensuring each dose increase is appropriate based on individual tolerance and response.

Wegovy Doses: Maintenance Dose and Long-Term Treatment

Long-term treatment with wegovy doses requires ongoing clinical monitoring and prescription renewal. The 2.4mg maintenance dose should be continued as long as the treatment remains clinically beneficial and well-tolerated. MHRA licensing for Wegovy specifies that treatment should be discontinued if patients have not lost at least 5% of initial body weight after 12 weeks at the maintenance dose[3].

Some patients may find that lower wegovy doses—such as 1.7mg weekly—provide adequate weight loss with better tolerability. Our prescribers can adjust maintenance wegovy doses based on individual response, treatment goals, and side effect profile. This flexible dosing approach ensures each patient receives the most appropriate wegovy dose for their circumstances whilst maintaining safety and efficacy standards.

The 2.4mg Maintenance Wegovy Dose

The therapeutic maintenance wegovy dose is 2.4mg administered once weekly via subcutaneous injection. This dose strength represents the optimal balance between weight loss efficacy and side effect profile as established in the STEP clinical trial programme[2]. Once patients reach this maintenance wegovy dose—typically after 16-20 weeks of escalation—they continue at 2.4mg weekly for ongoing weight management.

Clinical data shows that the 2.4mg maintenance wegovy dose produces sustained weight loss when combined with reduced-calorie diet and increased physical activity. In STEP trials, participants maintaining the 2.4mg dose for 68 weeks achieved significant reductions in body weight, waist circumference, and cardiovascular risk markers[2]. At Cured Pharmacy, we supply the 2.4mg maintenance wegovy dose from £69.00 per pen, subject to prescriber approval following your online assessment.

How Wegovy Doses Compare to Other Weight Loss Treatments

When evaluating wegovy doses against alternative weight loss medications, semaglutide's once-weekly dosing schedule offers distinct advantages. Unlike daily liraglutide injections (Saxenda) or twice-daily tirzepatide options, wegovy doses require just one injection per week, significantly improving treatment adherence and patient satisfaction[4].

The maximum wegovy dose of 2.4mg semaglutide weekly has demonstrated superior weight loss outcomes compared to other GLP-1 receptor agonists at their approved doses. Head-to-head comparisons show that wegovy doses produce greater average weight reduction than liraglutide 3mg daily, though newer dual-agonist medications like tirzepatide show comparable or superior results at higher dose tiers[4].

Wegovy doses are specifically formulated and licensed for chronic weight management, distinguishing them from Ozempic (semaglutide for type 2 diabetes). Whilst Ozempic contains the same active ingredient, its maximum licensed dose is 1mg weekly—significantly lower than the therapeutic wegovy doses used for weight loss. Using Ozempic off-label for weight management means patients receive sub-optimal semaglutide dosing compared to the evidence-based wegovy doses protocol[3].

Managing Side Effects Across Different Wegovy Doses

Managing side effects across wegovy doses involves both pharmacological and lifestyle strategies. Taking each wegovy dose on the same day each week, staying well-hydrated, eating smaller meals, and avoiding high-fat foods can significantly reduce gastrointestinal symptoms. Our pharmacy team provides detailed guidance on optimising tolerance at each wegovy dose level, ensuring patients can progress through the escalation schedule successfully.

Rare but serious side effects can occur with wegovy doses, including pancreatitis, gallbladder disease, and thyroid tumours (observed in rodent studies)[1]. All patients receiving wegovy doses should be counselled on warning signs and monitored appropriately. At Cured Pharmacy, every prescription includes comprehensive patient information and access to our clinical support team throughout treatment.

Common Side Effects at Each Wegovy Dose Level

Side effect profiles vary across different wegovy doses, with gastrointestinal symptoms being most common during dose escalation. At lower wegovy doses (0.25mg and 0.5mg), approximately 20-30% of patients experience mild nausea, whilst this increases to 40-45% at higher doses[2]. The graduated wegovy doses schedule specifically aims to minimise these effects by allowing physiological adaptation at each tier.

Most side effects associated with wegovy doses are transient and resolve within days to weeks as the body adjusts. Nausea, constipation, diarrhoea, and abdominal discomfort are most pronounced during the first few days after each wegovy dose increase, then typically diminish. Severe or persistent side effects warrant dose adjustment or temporary pause in escalation, which our clinical team can facilitate through your ongoing care plan.

Wegovy Doses Pricing and Accessing Treatment in the UK

Accessing wegovy doses through Cured Pharmacy requires completion of a brief online clinical assessment by our UK-registered prescribers. This consultation—which takes under three minutes—ensures wegovy doses are clinically appropriate for your circumstances, evaluating factors such as BMI, weight loss history, contraindications, and treatment goals. All wegovy doses are prescription-only medicines and cannot be supplied without prescriber approval[3].

We supply genuine UK-licensed wegovy doses with next-day delivery in discreet packaging. As a GPhC-registered online pharmacy (registration 9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), we adhere to all regulatory requirements for prescription medicine supply. Our wegovy doses come directly from licensed UK wholesalers, ensuring authenticity and proper storage throughout the supply chain. For clinical questions about wegovy doses or your treatment plan, contact our pharmacy team on (+44) 116 4646009.

Transparent Wegovy Doses Pricing at Cured Pharmacy

At Cured Pharmacy, wegovy doses are available from £69.00, representing the most competitive UK pricing for this licensed weight loss treatment. We display transparent pricing before your consultation, eliminating hidden fees or unexpected costs. New patients can Save £20 on their first order using code Weightlossnew, reducing the initial wegovy dose cost to just £69.00.

Each wegovy dose pen is supplied as a single-use, pre-filled injection device containing one weekly dose. The cost per wegovy dose remains consistent across all strengths—whether you're starting at 0.25mg or maintaining at 2.4mg, the per-pen price is the same. This pricing structure makes budgeting for the complete wegovy doses escalation protocol straightforward and predictable.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 13 August 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy (semaglutide): UK regulatory approval for chronic weight management. GOV.UK. [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.